The effects of illness on urinary catecholamines and their metabolites in dogs
K N Cameron1, W E Monroe, D L Panciera
1Department of Small Animal Clinical Sciences, Virginia-Maryland Regional College of Veterinary Medicine, Blacksburg, VA 24061, USA. kcameron@vt.edu
Background:
Urinary catecholamines and metanephrines have been proposed as a diagnostic tool for identifying canine pheochromocytomas, but the effects of critical illness on urine concentrations of catecholamines and metanephrines currently are unknown.
Objectives:
To examine the effects of illness on urine concentrations of catecholamines and metanephrines in dogs.
Animals:
Twenty-five critically ill dogs and 25 healthy age- and sex-matched control dogs.
Methods:
Prospective observational study. Urine was collected from healthy and critically ill dogs, and urine concentrations of epinephrine, norepinephrine, metanephrine, and normetanephrine were measured by high-performance liquid chromatography with electrochemical detection. Urinary catecholamine and metanephrine:creatinine ratios were calculated and compared between groups.
Results:
Urinary epinephrine, norepinephrine, metanephrine, and normetanephrine:creatinine ratios were higher in critically ill dogs when compared with a healthy control population (P=.0009, P<0.0001, P<0.0001, and P<0.0001, respectively).
Conclusions And Clinical Importance:
Illness has a significant impact on urinary catecholamines and their metabolites in dogs. Further investigation of catecholamine and metanephrine concentrations in dogs with pheochromocytomas is warranted to fully evaluate this test as a diagnostic tool; however, the findings of this study suggest that the results may be difficult to interpret in dogs with concurrent illness.
Related Concept Videos
Urine Studies I: Urinalysis
Physiology of Urine Formation
Glomerular Filtration
The first stage in urine formation is glomerular filtration. Each kidney contains approximately 1 million nephrons, the functional units of filtration, with a...
Drugs Affecting Neurotransmitter Release or Uptake
Physiology of the Genitourinary System III: Urine Concentration and Dilution
Chronic Kidney Disease II: Clinical Manifestations
Drugs Affecting Neurotransmitter Synthesis


